Carolina Pinto Vieira
Overview
Explore the profile of Carolina Pinto Vieira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thomaz M, Vieira C, Caris J, Marques M, Rocha A, Paz T, et al.
Pharmaceuticals (Basel)
. 2024 Jul;
17(7).
PMID: 39065716
This study aims to evaluate the impact of liver fibrosis stages of chronic infection with hepatitis C virus (HCV) on the in vivo activity of organic cation transporters (hepatic OCT1...
2.
Pippa L, Vieira C, Caris J, Rocha A, Marques M, Garcia C, et al.
Clin Pharmacol Ther
. 2023 Apr;
114(1):173-181.
PMID: 37070971
The activity of the membrane transporters organic anion-transporting polypeptide 1B1 (OATP1B1) & breast cancer resistance protein (BCRP) (rosuvastatin) and P-glycoprotein (P-gp) (fexofenadine) was evaluated in patients with chronic hepatitis C...
3.
Pippa L, Vieira C, Caris J, Rocha A, Garcia C, Rezende R, et al.
Br J Clin Pharmacol
. 2021 Mar;
87(10):4013-4019.
PMID: 33738827
Aims: Infection by the hepatitis C virus (HCV) generates inflammatory response selectively modulating cytochrome P450 protein (CYP) activities. This study assessed the effect of chronic hepatitis C on CYP2C19 activity...
4.
Vieira C, Neves D, Nardotto G, Cesarino E, Rocha A, Zanardi A, et al.
Eur J Clin Pharmacol
. 2020 Jan;
76(5):735-737.
PMID: 31982921
No abstract available.
5.
Neves D, Vieira C, Rocha A, Lanchote V
J Pharm Pharm Sci
. 2018 Jun;
21(1):236-246.
PMID: 29949502
Purpose: Ceftriaxone elimination occurs through breast cancer resistance transporter (BCRP) and multidrug resistance-associated protein 2 (MRP-2) which are expressed on the canalicular membrane of hepatocytes. Eltrombopag, a thrombopoetin receptor agonist...
6.
Vieira C, Neves D, Cesarino E, Rocha A, Poirier S, Lanchote V
J Pharm Biomed Anal
. 2017 Feb;
144:25-30.
PMID: 28209351
Nebivolol is a racemate of the d-isomer responsible for β adrenergic receptor antagonism and the l-isomer responsible for the release of nitric oxide from endothelial cells. Nebivolol is mainly metabolized...
7.
Neves D, Vieira C, Coelho E, Marques M, Lanchote V
J Chromatogr B Analyt Technol Biomed Life Sci
. 2013 Oct;
940:47-52.
PMID: 24141040
Nebivolol is available for clinical use as a racemic mixture. Isomer d-nebivolol (SRRR) is a β1 adrenergic receptor blocker and its antipode, l-nebivolol (RSSS) is responsible for endothelium-dependent NO liberation....